Chloe FERAL | Biochemistry | Best Researcher Award

Posted on by ScienceFather

Chloe FERAL | Biochemistry | Best Researcher Award

Mrs Chloe FERAL, INSERM, France

Based on Mrs. Chloé Féral’s impressive credentials and contributions, she appears to be a highly suitable candidate for the Best Researcher Award.

Publication profile

Orcid

Research Excellence and Achievements

Current Position: Research Director (DR2) at INSERM, France, with significant roles in leading the “Epithelial homeostasis and tumorigenesis” team at IRCAN. Education: Acquired a PhD with honors and Habilitation (HDR), showcasing a strong foundation in Cell and Molecular Pharmacology. Awards and Fellowships: Received prestigious awards such as the Sanofi iAward and multiple grants from INCA and ARC, highlighting her contributions to translational research and cancer studies.

Research Contributions

Publications: Authored numerous high-impact journal articles, including in Scientific Reports, Cell Death & Differentiation, and International Journal of Molecular Sciences. Her research spans critical areas like epithelial homeostasis, tumorigenesis, and cancer biology. Patents: Holds a patent for methods and compositions for treating skin afflictions, demonstrating her innovative approach in research.

Leadership and Impact

Organizational Roles: Organized major scientific meetings and held several institutional responsibilities, such as serving on scientific advisory boards and council boards. Teaching Activity: Actively involved in teaching and training, including lecturing at prestigious institutions like the École Polytechnique Paris.

Scientific Community Engagement

Memberships and Committees: Engaged in various scientific societies and committees, contributing to the evaluation and guidance of research and academic activities.

Notable Research Highlights

Her work on epithelial stem cell fate and tumorigenesis, as well as advancements in cancer research, underlines her role as a leading figure in her field.

Awards

Dr. Chloe FERAL has been recognized for significant contributions in translational research. As Principal Investigator (PI), they led the Sanofi iAward EUROPE for Translational Research (2020-2021) and secured the PL-Bio Grant from INCA (2019-2023), collaborating with a team consortium. They also received the IDEX-UCAJEDI Prematuration grant from the University Côte d’Azur (2019-2020). The Excellency Program from “La Ligue Contre le Cancer” (2014-2018) and the COPOC2018 Inserm Transfert Award (2018) further highlight their achievements. Additionally, Dr. [Name] received ARC Project Awards in 2016-2017 and 2018-2019. 🏆🔬🧬

Publication top notes

The biophysical property of the limbal niche maintains stemness through YAP

Fibroblast growth factor-2 bound to specific dermal fibroblast-derived extracellular vesicles is protected from degradation

Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine

Fibronectin meshwork controls epithelial stem cell fate

Soft limbal niche maintains stem cell compartmentalization and function through YAP

A ganglioside-based senescence-associated immune checkpoint

A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.

 

 

Nida Sohail | Biochemistry Award | Best Researcher Award

Posted on by ScienceFather

Dr. Nida Sohail | Biochemistry Award | Best Researcher Award

Dr. Nida Sohail, Muhammadi Blood Bank and Thalassemia Centre, Pakistan

Dr. Sahar Zaidi is an Associate Professor at the Department of Botany, Federal Urdu University of Arts, Sciences and Technology, Karachi, Pakistan. Her research interests include plant biology, with a focus on medicinal plants and their biochemical properties. She is actively involved in teaching and research, contributing to advancements in plant molecular biology

Publication profile

Orcid

📚 Academic and Professional Background

Dr. Sohail enriches academic discourse through her publications and conference presentations. She is committed to scientific inquiry, evident in her role as a peer reviewer and her active participation in international conferences.

Research Focus

Nida Sohail’s research focuses on the therapeutic potential of marine macroalgae, particularly in mitigating drug-induced nephrotoxicity and hepatotoxicity. Her work integrates biochemical assays, histopathological analyses, and molecular techniques to explore natural product-based therapies for organ protection. She also investigates the antibacterial and nematicidal properties of endophytic fungi through GC-MS profiling, contributing to agricultural and environmental sciences. Additionally, she studies the impacts of natural products on diabetes, hyperlipidemia, and liver/kidney dysfunctions. 🌿 Her multidisciplinary approach underscores a commitment to biochemistry, environmental science, and pharmaceutical research for health and ecological benefits.

 

Publication Top Notes

 

Nadia Okasha | Biochemistry | Young Scientist Award

Posted on by ScienceFather

Ms. Nadia Okasha | Biochemistry | Young Scientist Award

Ms. Nadia Okasha, College of Biotechnology, Misr University for Science and Technology, Egypt

👩‍🔬 Nadia I. Okasha, an Egyptian biotechnologist, holds a BSc in Biotechnology with honors and an MSc in Environmental Biotechnology. Her research focuses on antiviral compounds from Egyptian marine life. With expertise in molecular techniques and statistical analysis, she contributes to academia as an Assistant Lecturer, while also engaging in various workshops and committees. Fluent in Arabic and English, Nadia’s interests span scientific research, presentation skills, and athletics, including high jump. Passionate about learning and knitting, she brings a dynamic blend of skills to her pursuits.

Publication Profile:

Scopus

Education:

👩‍🔬 Nadia Okasha is a dedicated biotechnologist with a BSc in Biotechnology from Misr University for Science and Technology (MUST), achieving top honors with a GPA of 4 and ranking 2nd out of 163 students. She furthered her education with an MSc in Environmental Biotechnology, specializing in extracting and identifying potential antiviral compounds from Egyptian starfish, targeting MERS-CoV and H1N1. Complementing her academic journey, Nadia has undertaken pre-master courses in diverse fields like nanotechnology and bioremediation. Engaging in workshops ranging from statistical analysis to molecular docking, she is adept at scientific research and communication, enhancing her expertise in bioengineering. 🧬📚

Working Experience:

👩‍🔬 Nadia I. Okasha, an Egyptian Assistant Lecturer, brings a wealth of academic and practical experience to her role. With a background in Biotechnology and Environmental Biotechnology, Nadia excels in various laboratory techniques, including antiviral assays, karyotyping, and electrophoresis. Her diverse skill set extends to plant tissue culture, microbiology, and chromatography techniques. Adept in scientific research, Nadia has a keen eye for detail and proficiency in computational tools like molecular docking and molecular modeling systems. Her six-month training at El Motamyz Laboratory enhanced her expertise in real-time PCR and medical analysis. As a Teaching Assistant at Misr University for Science and Technology, she actively contributes to students’ learning and academic development. Notably, Nadia organized the “2nd International Biotechnology Conference,” demonstrating her leadership and organizational skills. Fluent in Arabic and English, she possesses excellent presentation skills and is passionate about continuous learning, sports, and knitwear work.

Research Focus:

🔬 Nadia I. Okasha’s research focuses on identifying potential antiviral compounds from Egyptian sea stars, particularly targeting seasonal influenza A/H1N1 virus. Her work, published in the Journal of Genetic Engineering and Biotechnology, demonstrates her dedication to exploring natural sources for pharmaceutical development. By investigating the antiviral properties of sea star extracts, Nadia contributes to the advancement of medical science, aiming to combat prevalent viral infections. Her research aligns with biotechnology and pharmaceutical sciences, aiming to harness the rich biodiversity of marine organisms for therapeutic purposes. Through this endeavor, Nadia exemplifies the interdisciplinary nature of biotechnological research and its potential in addressing global health challenges. 🌊🌟

Publication Top Note:

Identification of potential antiviral compounds from Egyptian sea stars against seasonal influenza A/H1N1 virus

 

Effat Alizadeh | Biochemistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Effat Alizadeh | Biochemistry | Best Researcher Award

Assoc Prof Dr. Effat Alizadeh, Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Iran

👩‍🔬 Dr. Effat Alizadeh is an accomplished researcher and educator in the field of biotechnology, specializing in stem cell applications and genetic engineering. With a diverse academic background spanning from cell biology to medical biotechnology, she holds a Ph.D. from Tabriz University of Medical Sciences and conducted postdoctoral research at Karolinska Institute, Sweden. Dr. Alizadeh has authored books and patents, notably in cell sheet technology and hepatic commitment of stem cells. Recognized for her contributions, she has received numerous awards and held leadership roles in academia. As a dedicated member of scientific societies, she continues to advance research in regenerative medicine and biotechnology.

Publication Profile:

Scopus

Orcid

Google Scholar

Education:

🎓 Dr. Effat Alizadeh’s academic journey has been marked by a profound dedication to advancing knowledge in the realms of biotechnology and regenerative medicine. Her pursuit of excellence began with a Bachelor’s degree in Cell and Molecular Biology from Alzahra University in Tehran, where she laid the foundation for her future endeavors. Building upon this strong foundation, she further honed her expertise with a Master’s degree in Cell and Molecular Biology from Shahid Beheshti University in Tehran, delving deeper into the intricacies of cellular mechanisms.Driven by a passion for cutting-edge research, Dr. Alizadeh pursued a Ph.D. in Medical Biotechnology at Tabriz University of Medical Sciences, where she demonstrated her commitment to advancing the frontiers of biomedicine. Her doctoral studies provided her with invaluable insights into the intersection of biotechnology and medical science, setting the stage for her subsequent contributions to the field.Eager to expand her horizons and delve into the emerging field of gene therapy, Dr. Alizadeh embarked on a postdoctoral fellowship at the Division of Eye and Vision, Department of Clinical Neuroscience, St. Erik Eye Hospital, Karolinska Institute in Stockholm, Sweden. There, she focused her research efforts on cell and gene therapy for Macular Degeneration, contributing to groundbreaking advancements in ocular regenerative medicine.Throughout her academic journey, Dr. Alizadeh’s unwavering commitment to excellence and innovation has been evident, propelling her to the forefront of her field and earning her accolades and recognition from her peers. As she continues to push the boundaries of scientific discovery, her contributions promise to shape the future of biotechnology and regenerative medicine. 🧬✨

Teaching Experiences:

📚 Dr. Effat Alizadeh’s teaching experiences reflect her diverse expertise and dedication to fostering knowledge in the fields of biotechnology and life sciences. She has imparted her extensive knowledge to both undergraduate and postgraduate students, covering topics ranging from the fundamentals of biotechnology to advanced applications in stem cell research and genetic engineering. With a focus on practical relevance, Dr. Alizadeh has engaged students in courses such as Bioinformatics and Microbiology, equipping them with essential skills for their academic and professional pursuits. Her passion for education shines through in her commitment to nurturing the next generation of scientists and biotechnologists. 🧬🎓

Honors & Awards:

🏅 Dr. Effat Alizadeh’s illustrious career is adorned with numerous honors and accolades, underscoring her exceptional achievements and contributions to the field of medical sciences. Recognized as the Top Young Researcher among Medical Universities in 2023, she continues to push the boundaries of knowledge in her field. Serving as the Scientific Chairwoman of the National Symposium of Advanced Medical Science and Technologies in Tabriz further exemplifies her leadership and expertise. From being lauded as the Top Researcher of the Faculty of Advanced Medical Sciences to securing scholarships for her academic excellence, Dr. Alizadeh’s journey is marked by consistent distinction and a commitment to excellence. 🌟👩‍🔬

Research Focus:

🔬 Dr. Effat Alizadeh’s research focuses on the innovative applications of stem cells and nanotechnology in regenerative medicine and cancer therapy. She explores the potential of stem cell differentiation for tissue regeneration and investigates novel drug delivery systems utilizing nanoparticles for targeted cancer treatment. With a keen interest in both basic and translational research, Dr. Alizadeh contributes significantly to understanding cellular mechanisms and developing cutting-edge therapies. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in areas such as liver fibrosis, colon cancer, and acute leukemia. 🧫🔍

Publication Top Notes:

Preparation and in vitro evaluation of cell adhesion and long-term proliferation of stem cells cultured on silibinin co-embedded PLGA/Collagen electrospun composite nanofibers

A Systematic Review of Stem Cell Differentiation into Keratinocytes for Regenerative Applications

An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications

Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling

Sodium selenite preserves rBM-MSCs’ stemness, differentiation potential, and immunophenotype and protects them against oxidative stress via activation of the Nrf2 signaling pathway

In silico targeting breast cancer biomarkers by applying rambutan (Nephelium lappaceum) phytocompounds

Uncovering key molecular mechanisms in the early and late-stage of papillary thyroid carcinoma using association rule mining algorithm

Efficient targeting of HIF-1α mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy

An efficient method for cell sheet bioengineering from rBMSCs on thermo-responsive PCL-PEG-PCL copolymer

Urinary MicroRNAs, Possible Biomarkers for Early Detection of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

 

 

 

 

 

 

Ahmed Khedr | Biochemistry | Excellence in Research

Posted on by ScienceFather

Assist Prof Dr. Ahmed Khedr | Biochemistry | Excellence in Research

Assist Prof Dr. Ahmed, Faculty of Medicine, Helwan University, Egypt

🎓 Dr. Ahmed Khedr, PhD, is an Assistant Professor in Medical Biochemistry and Molecular Biology at Batterjee Medical College, Aseer, Saudi Arabia. He holds a PhD from Cairo University in Medical Biochemistry, focusing on miRNA and lncRNA expressions in systemic sclerosis. With a passion for teaching, Dr. Khedr has instructed various medical biochemistry courses across multiple universities, impacting students globally. His research interests include molecular mechanisms in autoimmune diseases. Recognized for his contributions, he received awards for his commitment to quality education and community service. Dr. Khedr continues to inspire and educate future healthcare professionals through his expertise and dedication.

Publication Profile:

Scopus

Qualifications:

🎓 Dr. Ahmed Khedr is a highly qualified professional with a diverse academic background and expertise in Medical Biochemistry and Molecular Biology. He earned his Bachelor of Medicine and Surgery (MBBCH) from Benha University in 2014, laying the foundation for his medical career. Dr. Khedr furthered his education with a Master of Science degree from Cairo University in 2021, where he delved into the intricate relationship between miRNA-22 and serum levels of vitamin D and its receptor in patients with multiple sclerosis, contributing to the understanding of this complex disease.Driven by his passion for research, Dr. Khedr pursued a Doctor of Philosophy degree from Cairo University, which he completed in July 2023. His doctoral thesis focused on exploring the expression of miRNA-133 and lncRNA-H19 and their correlation with serum levels of PKM2 and TGF-β in patients diagnosed with systemic sclerosis, shedding light on potential biomarkers and molecular pathways involved in the pathogenesis of the disease.With his extensive academic journey and research accomplishments, Dr. Khedr stands as a dedicated scholar committed to advancing knowledge in his field and making meaningful contributions to the medical community.

Employments:

👨‍🏫 Dr. Ahmed Khedr’s professional journey reflects a commitment to academia and healthcare. His career began as a House Officer at Benha University Hospitals from March 2015 to February 2016, where he gained valuable clinical experience in a hospital setting. Transitioning to a role as a General Practitioner with the Ministry of Health in the Qalyubiya government from March 2016 to January 2017, Dr. Khedr contributed to public health initiatives, serving the community with dedication.His passion for education led him to join the University of Cairo as a Demonstrator from February 2017 to December 2020, where he nurtured the academic growth of aspiring healthcare professionals. In January 2021, Dr. Khedr advanced to the position of Assistant Lecturer at the Faculty of Medicine, Helwan, further honing his skills in teaching and research.Currently, Dr. Khedr holds the esteemed position of Assistant Professor in the Medical Biochemistry and Molecular Biology Department at Batterjee Medical College since May 2023. In this role, he continues to inspire and mentor students while conducting groundbreaking research in his field, shaping the future of healthcare through education and innovation.

Awards and Recognition:

🏅 Dr. Ahmed Khedr’s dedication to excellence and service has been recognized through notable awards and recognition. In February 2019, he received an appreciation certificate for his participation in the Quality Assurance and Accreditation Unit and community services at the Faculty of Medicine, Helwan University. Additionally, in January 2019, Dr. Khedr was selected as a qualified member of the first aid workshop held at the same institution, showcasing his commitment to healthcare and education. These accolades underscore his passion for contributing to the advancement of medical education and community well-being.

Teaching experience:

👨‍🏫 Dr. Ahmed Khedr’s teaching experience spans various prestigious institutions, reflecting his expertise and dedication to education. Since 2023, he has been imparting medical biochemistry courses and exams to students at Batterjee Medical College in Aseer, Saudi Arabia, catering to the faculties of Medicine, Nursing, and Respiratory Therapy. Prior to this, Dr. Khedr taught medical biochemistry at Badr University in Egypt from 2019 to 2023, engaging students from faculties including Physical Therapy, Oral and Dental Medicine, and Allied Health Sciences. Additionally, he facilitated medical biochemistry courses at Ahram Canadian University and Helwan University, underscoring his commitment to nurturing future healthcare professionals. 📚

Research Focus:

🔬 Dr. Ahmed Khedr’s research focus primarily revolves around the intricate mechanisms underlying non-coding RNAs, particularly microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), and their involvement in various pathological conditions. His studies explore the roles of miRNAs and lncRNAs in systemic sclerosis, alopecia areata, and multiple sclerosis, elucidating their interactions with key signaling molecules such as PKM2, TGF-β1, and vitamin D receptor. Through his investigations, Dr. Khedr aims to uncover novel biomarkers and therapeutic targets for these diseases, contributing to advancements in precision medicine and personalized treatment approaches. 🧬

Publication Top Notes:

miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis

Expression of Long Noncoding RNA, HOTAIR, and MicroRNA-205 and Their Relation to Transforming Growth Factor β1in Patients with Alopecia Areata

MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels